» Articles » PMID: 32977419

Pyrroloquinoline Quinone Inhibits Rotenone-Induced Microglia Inflammation by Enhancing Autophagy

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2020 Sep 26
PMID 32977419
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Neuroinflammation is a feature common to neurodegenerative diseases, such as Parkinson's disease (PD), which might be responsive to therapeutic intervention. Rotenone has been widely used to establish PD models by inducing mitochondrial dysfunction and inflammation. Our previous studies have reported that pyrroloquinoline quinone (PQQ), a naturally occurring redox cofactor, could prevent mitochondrial dysfunction in rotenone induced PD models by regulating mitochondrial functions. In the present study, we aimed to investigate the effect of PQQ on neuroinflammation and the mechanism involved. BV2 microglia cells were pre-treated with PQQ followed by rotenone incubation. The data showed that PQQ did not affect the cell viability of BV2 cells treated with rotenone, while the conditioned medium (CM) of BV2 cells pre-treated with PQQ significantly increased cell viability of SH-SY5Y cells. In rotenone-treated BV2 cells, PQQ dose-dependently decreased lactate dehydrogenase (LDH) release and suppressed the up-regulation of pro-inflammation factors, such as interleukin-1β (IL-1β), IL-6 and tumor necrosis factor-α (TNF-α) in the cultured media, as well as nitric oxide (NO) release induced by rotenone. PQQ pretreatment also increased the ratio of LC3-II/LC3-I and expression of Atg5 in BV2 cells stimulated with rotenone. Additionally, the autophagosome observed by transmission electron microscopy (TEM) and co-localization of mitochondria with lysosomes indicated that mitophagy was induced by PQQ in rotenone-injured BV2 cells, and the PINK1/parkin mediated mitophagy pathway was regulated by PQQ. Further, autophagy inhibitor, 3-methyladenine (3-MA), partially abolished the neuroprotective effect of PQQ and attenuated the inhibition of inflammation with PQQ pretreatment. Taken together, our data extend our understanding of the neuroprotective effect of PQQ against rotenone-induced injury and provide evidence that autophagy enhancement might be a novel therapeutic strategy for PD treatment.

Citing Articles

Characterization of Walnut Oil and Evaluation of Its Neuroprotective Effects in an In Vitro Model of Parkinson's Disease.

Filaferro M, Avallone R, Rustichelli C, Vitale G Molecules. 2024; 29(23).

PMID: 39683877 PMC: 11643845. DOI: 10.3390/molecules29235718.


Rotenone-Induced Optic Nerve Damage and Retinal Ganglion Cell Loss in Rats.

Yamamoto Y, Taniguchi T, Shimazaki A Biomolecules. 2024; 14(9).

PMID: 39334813 PMC: 11430293. DOI: 10.3390/biom14091047.


Metabolic and Biochemical Effects of Pyrroloquinoline Quinone (PQQ) on Inflammation and Mitochondrial Dysfunction: Potential Health Benefits in Obesity and Future Perspectives.

Charrier D, Cerullo G, Carpenito R, Vindigni V, Bassetto F, Simoni L Antioxidants (Basel). 2024; 13(9).

PMID: 39334686 PMC: 11429417. DOI: 10.3390/antiox13091027.


Pyrroloquinoline quinone protects against murine hepatitis virus strain 3-induced fulminant hepatitis by inhibiting the Keap1/Nrf2 signaling.

Pu Z, Ge F, Zhou Y, Liu A, Yang C Cytotechnology. 2024; 76(4):441-452.

PMID: 38933874 PMC: 11196452. DOI: 10.1007/s10616-024-00627-0.


Mini-encyclopedia of mitochondria-relevant nutraceuticals protecting health in primary and secondary care-clinically relevant 3PM innovation.

Golubnitschaja O, Kapinova A, Sargheini N, Bojkova B, Kapalla M, Heinrich L EPMA J. 2024; 15(2):163-205.

PMID: 38841620 PMC: 11148002. DOI: 10.1007/s13167-024-00358-4.


References
1.
Wu Y, Tan H, Shui G, Bauvy C, Huang Q, Wenk M . Dual role of 3-methyladenine in modulation of autophagy via different temporal patterns of inhibition on class I and III phosphoinositide 3-kinase. J Biol Chem. 2010; 285(14):10850-61. PMC: 2856291. DOI: 10.1074/jbc.M109.080796. View

2.
Zhang Q, Chen S, Yu S, Qin J, Zhang J, Cheng Q . Neuroprotective effects of pyrroloquinoline quinone against rotenone injury in primary cultured midbrain neurons and in a rat model of Parkinson's disease. Neuropharmacology. 2016; 108:238-51. DOI: 10.1016/j.neuropharm.2016.04.025. View

3.
Tabata Y, Imaizumi Y, Sugawara M, Andoh-Noda T, Banno S, Chai M . T-type Calcium Channels Determine the Vulnerability of Dopaminergic Neurons to Mitochondrial Stress in Familial Parkinson Disease. Stem Cell Reports. 2018; 11(5):1171-1184. PMC: 6234903. DOI: 10.1016/j.stemcr.2018.09.006. View

4.
Nixon R . The role of autophagy in neurodegenerative disease. Nat Med. 2013; 19(8):983-97. DOI: 10.1038/nm.3232. View

5.
Johnson M, Bobrovskaya L . An update on the rotenone models of Parkinson's disease: their ability to reproduce the features of clinical disease and model gene-environment interactions. Neurotoxicology. 2014; 46:101-16. DOI: 10.1016/j.neuro.2014.12.002. View